SpecialtiesQuestion

In patients with BMI <30 but with obesity-related comorbidities (e.g., OSA, prediabetes, NAFLD), how comfortable are you initiating GLP-1s?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

In what situations would you recommend metformin in addition to aggressive lifestyle interventions for patients with prediabetes and obesity?

In patients with MASLD, would you consider management with off-label metformin, pioglitazone (despite weight gain risk), GLP-1 RA, or simply intensify lifestyle and monitor?

Would you consider pharmacotherapy (i.e., GLP1-agonist) or behavioral/nutrition interventions alone in a patient with a remote history of a restrictive eating disorder now presenting with obesity and metabolic complications?

How do you decide which GLP-1s to prescribe for obesity?

How have the new USDA Dietary Guidelines which seem to promote several sources of saturated fat (i.e., full fat dairy products, butter, red meat) changed how you approach dietary advice with your patients?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.